Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages 972-977

  Klein, Rachel S ^a   Dunlop, James D ^b   Samimi, Sara S ^a   Morrissey, Kelly A ^a   Evans, Katherine G ^a   Gardner, Jennifer M ^c   Introcaso, Camille E ^d   Vittorio, Carmela C ^a   Rook, Alain H ^a   Micaily, Bizhan ^e   Kim, Ellen J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PENNSYLVANIA HOSPITAL   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cutaneous T cell lymphoma; flow cytometry; mycosis fungoides; radiation therapy; S zary syndrome; skin directed therapy; total skin electron beam

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; RETINOID;

ADVANCED CANCER; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; MULTIMODALITY CANCER THERAPY; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEZARY SYNDROME; SYSTEMIC THERAPY; THERAPY EFFECT; TOTAL SKIN ELECTRON THERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE COUNT; MYCOSIS FUNGOIDES; PROGNOSIS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SEZARY SYNDROME; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN; WHOLE-BODY IRRADIATION;

EID: 84877799139     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.09.056     Document Type: Article

References (14)

1. R. Willemze, E.S. Jaffe, G. Burg, L. Cerroni, E. Berti, and S.H. Swerdlow WHO-EORTC classification for cutaneous lymphomas Blood 105 2005 3768 3785
2. E. Olsen, E. Vonderheid, N. Pimpinelli, R. Willemze, Y. Kim, and R. Knobler Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC) Blood 110 2007 1713 1722
3. E.A. Olsen, A.H. Rook, J. Zic, Y. Kim, P. Porcu, and C. Querfeld Sézary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC) J Am Acad Dermatol 64 2011 352 404
4. E.C. Vonderheid, M.G. Bernengo, G. Burg, M. Duvic, P. Heald, and L. Laroche Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas J Am Acad Dermatol 46 2002 95 106
5. N.S. Agar, E. Wedgeworth, S. Crichton, T.J. Mitchell, M. Cox, and S. Ferreira Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organization for Research and Treatment of Cancer staging proposal J Clin Oncol 28 2010 4730 4739
6. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology nonHodgkin's lymphomas, mycosis fungoides and Sezary syndrome. Version 3. 2011.
7. F. Trautinger, R. Knobler, R. Willemze, K. Peris, R. Stadler, and L. Laroche EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome Eur J Cancer 42 2006 1014 1030
8. G.W. Jones, B.M. Kacinski, L.D. Wilson, R. Willemze, M. Spittle, and G. Hohenberg Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group J Am Acad Dermatol 47 2002 364 370
9. L.D. Wilson, G.W. Jones, D. Kim, D. Rosenthal, I.R. Christensen, and R.L. Edelson Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides J Am Acad Dermatol 43 2000 54 60
10. C.E. Introcaso, B. Micaily, S.K. Richardson, J.M. Junkins-Hopkins, J.S. Yoon, and E.J. Kim Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome J Am Acad Dermatol 58 2008 592 595
11. E.A. Olsen, S. Whittaker, Y.H. Kim, M. Duvic, H.M. Prince, and S.R. Lessin Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organization for Research and Treatment of Cancer J Clin Oncol 29 2011 2598 2607
12. E.C. Halperin, C.A. Perez, and L.W. Brady Perez and Brady's principals and practices of radiation oncology 1998 Lippincott-Raven Philadelphia
13. E.K. Yoo, M. Cassin, S.R. Lessin, and A.H. Rook Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity J Am Acad Dermatol 45 2001 208 216
14. C. Harrison, J. Young, D. Navi, N. Riaz, B. Lingala, and Y. Kim Revisiting low-dose total skin electron beam therapy in mycosis fungoides Int J Radiat Oncol Biol Phys 81 2011 e651 e657